Interactive Brokers, T-Mobile US And 2 Other Stocks Insiders Are Selling
Portfolio Pulse from Avi Kapoor
Insiders at Interactive Brokers Group, T-Mobile US, Cano Health, and TransAct Technologies have recently sold shares. Interactive Brokers' CIO sold shares after an analyst upgrade and price target raise. T-Mobile's 10% owner sold shares amidst a senior notes sale. Cano Health's 10% owner sold shares following a NYSE non-compliance notice. TransAct Technologies' 10% owner sold shares after approval to sell a product in the U.S. market. Insider sales can indicate various sentiments and should not be the sole basis for investment decisions.
January 10, 2024 | 12:35 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cano Health's 10% owner ITC Rumba, LLC sold 75,000 shares at $3.81 each after the company received a NYSE non-compliance notice regarding market capitalization criteria.
The insider sale, coupled with the NYSE non-compliance notice, could be a strong negative signal to investors, likely resulting in downward pressure on the stock price in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
T-Mobile's 10% owner Deutsche Telekom Holding BV sold shares totaling $95.27M at an average price of $162.94, coinciding with the company's announcement of a $3 billion senior notes sale.
The large sale by a major owner could be viewed negatively by the market, especially as it aligns with a significant debt issuance, potentially leading to a short-term dip in the stock price.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 60
NEUTRAL IMPACT
Interactive Brokers' CIO sold shares worth $2.27M at $87.40 each after an analyst upgrade and price target increase from $88 to $102 by Goldman Sachs.
The sale by the CIO could be seen as a negative signal, but the recent analyst upgrade and raised price target could counterbalance the impact, leading to a neutral short-term effect on the stock price.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70
NEUTRAL IMPACT
TransAct Technologies' 10% owner Bryant Riley sold 28,842 shares at $7.52 each after the company received approval to sell its BOHA!® Terminal 2 in the U.S. market.
While the insider sale might raise concerns, the approval for BOHA!® Terminal 2 could have a positive impact. These opposing factors may lead to a neutral short-term impact on the stock price.
CONFIDENCE 65
IMPORTANCE 55
RELEVANCE 50